Corticosteroids API Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2024-2030

Overview of Global Corticosteroids API Market

The global Corticosteroids API market, valued at US$ 2206.26 million in 2022, is projected to witness substantial growth, reaching US$ 3309.40 million by 2029. This growth is anticipated to occur at a Compound Annual Growth Rate (CAGR) of 6.11% during the forecast period from 2023 to 2029.

Factors Driving Market Growth

  1. Increasing Demand for Corticosteroids

    • The rising prevalence of various inflammatory and autoimmune diseases is driving the demand for corticosteroids, contributing to market growth.
  2. Expanding Applications

    • Corticosteroids find applications in a wide range of therapeutic areas, including dermatology, respiratory disorders, and autoimmune conditions, fueling their market demand.
  3. Growing Pharmaceutical Industry

    • The pharmaceutical industry's expansion and advancements in drug development are positively impacting the Corticosteroids API market.

North American Market for Corticosteroids API

The North American market for Corticosteroids API is estimated to experience notable growth, increasing from $220.53 million in 2022 to reach $302.18 million by 2029. This represents a CAGR of 4.69% during the forecast period from 2023 to 2029.

Key Drivers for North American Growth

  1. Prevalence of Chronic Diseases

    • The high incidence of chronic diseases in North America, such as asthma and rheumatoid arthritis, is a significant factor contributing to the increased demand for corticosteroids.
  2. Technological Advancements

    • Ongoing technological advancements in pharmaceutical research and development in the region are fostering the production and utilization of Corticosteroids API.

European Market for Corticosteroids API

The European market for Corticosteroids API is projected to grow from $512.79 million in 2022 to $708.19 million by 2029, with a CAGR of 4.74% during the forecast period from 2023 to 2029.

Driving Factors for European Growth

  1. Aging Population

    • Europe's aging population is contributing to an increased incidence of age-related diseases, creating a higher demand for corticosteroid-based treatments.
  2. Government Initiatives

    • Supportive government initiatives and healthcare policies are influencing market growth by promoting the development and use of corticosteroids in various medical applications.

Major Global Manufacturers

The major global manufacturers of Corticosteroids API play a pivotal role in shaping the market landscape. In 2022, the top three vendors, including Pfizer CentreOne, EUROAPI, and GlaxoSmithKline, accounted for approximately 30.09% of the revenue.

Leading Manufacturers and their Contributions

  1. Pfizer CentreOne

    • Pfizer CentreOne stands out as a leading manufacturer, contributing significantly to the Corticosteroids API market. Its diverse product portfolio and research capabilities position it as a key player.

    • EUROAPI's expertise and market presence make it a crucial contributor to the Corticosteroids API industry, addressing the growing demand for these pharmaceutical ingredients.
  3. GlaxoSmithKline

    • As one of the major global manufacturers, GlaxoSmithKline's innovation and established reputation contribute substantially to the overall market share.
  4. Other Notable Manufacturers

    • Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, and Anuh Pharma are also noteworthy contributors, collectively shaping the competitive landscape.

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Corticosteroids API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Corticosteroids API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Pfizer CentreOne


  • GlaxoSmithKline

  • Teva Pharmaceutical Industries

  • Hovione

  • Axplora

  • Steroid SpA

  • Avik Pharmaceutical

  • Anuh Pharma

  • Symbiotec Pharmalab

  • Sun Pharmaceutical

  • Cipla

  • Wellona Pharma

  • Tianjin Tianyao Pharmaceuticals

  • Zhejiang Xianju Pharmaceutical

  • Guangdong VTR BioTech

  • Zhejiang Xianju Xianle Pharmaceutical

  • Tianjin Pacific Pharmaceutical

  • Shandong Xinhua Pharmaceutica Group

  • Jiangsu Lianhuan Pharmaceutical

  • Shanghai New Hualian Pharmaceutical

  • Shandong Taihua Biotech

  • Shandong Sito Bio-technolog

  • Zhejiang Xianju Junye Pharmaceutical

Segment by Type

  • Prednisone Series

  • Dexamethasone Series

  • Betamethasone Series

  • Hydrocortisone Series

  • Other

Segment by Application

  • Injectable Drugs

  • Oral Drugs

  • Topical Drugs

  • Inhaled Drugs

Production by Region

  • North America

  • Europe

  • China

  • Japan

Consumption by Region

  • North America

    • U.S.

    • Canada

  • Asia-Pacific

    • China

    • Japan

    • South Korea

    • Southeast Asia

    • India

  • Europe

    • Germany

    • France

    • U.K.

    • Italy

    • Russia

    • Rest of Europe

  • South America

    • Mexico

    • Brazil

    • Rest of South America